Alliance Pharma plc

LSE (GBp): Alliance Pharma plc (APH)

Last Price

64.51

Today's Change

-0.088 (0.13%)

Day's Change

64.51 - 64.599

Trading Volume

2,311

Profile
APH

Exchange:  London Stock Exchange London Stock Exchange

Currency:  GBp GBp

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Nicholas John Sedgwick Nicholas John Sedgwick

Full Time Employees:  290 290

IPO Date:  2001-11-22 2001-11-22

CIK: 

ISIN:  GB0031030819 GB0031030819

CUSIP:  G0179G102 G0179G102

Beta:  0.58 0.58

Last Dividend:  0.00 0.00

Dcf Diff:  40.18 40.18

Dcf:  24.02 24.02

Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Address

Avonbridge House,
Chippenham, SN15 2BB, GB

44 12 4946 6966

http://www.alliancepharmaceuticals.com

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment